-
2
-
-
0036512208
-
New functions for the matrix metalloproteinases in cancer progression
-
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2(3):161-174 (Pubitemid 37328786)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.3
, pp. 161-174
-
-
Egeblad, M.1
Werb, Z.2
-
3
-
-
0026425631
-
Tumor invasion and metastasis: An imbalance of positive and negative regulation
-
Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991;51(18 Suppl):5054s-9s
-
(1991)
Cancer Res
, vol.51
, Issue.18 SUPPL.
-
-
Liotta, L.A.1
Stetler-Stevenson, W.G.2
-
4
-
-
0030806173
-
Changing views of the role of matrix metalloproteinases in metastasis
-
Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89(17):1260-1270 (Pubitemid 27371946)
-
(1997)
Journal of the National Cancer Institute
, vol.89
, Issue.17
, pp. 1260-1270
-
-
Chambers, A.F.1
Matrisian, L.M.2
-
5
-
-
0029977810
-
MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis
-
Kinoh H, Sato H, Tsunezuka Y, et al. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 1996;109(Pt 5):953-959 (Pubitemid 26168248)
-
(1996)
Journal of Cell Science
, vol.109
, Issue.5
, pp. 953-959
-
-
Kinoh, H.1
Sato, H.2
Tsunezuka, Y.3
Takino, T.4
Kawashima, A.5
Okada, Y.6
Seiki, M.7
-
6
-
-
0028907318
-
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
-
Strongin AY, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270(10):5331-5338
-
(1995)
J Biol Chem
, vol.270
, Issue.10
, pp. 5331-5338
-
-
Strongin, A.Y.1
Collier, I.2
Bannikov, G.3
-
7
-
-
0030037395
-
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme
-
DOI 10.1074/jbc.271.29.17124
-
Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271(29):17124-17131 (Pubitemid 26244262)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.29
, pp. 17124-17131
-
-
Knauper, V.1
Will, H.2
Lopez-Otin, C.3
Smith, B.4
Atkinson, S.J.5
Stanton, H.6
Hembry, R.M.7
Murphy, G.8
-
9
-
-
0032850365
-
Matrix metalloproteinases in tumour invasion and metastasis
-
DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2- C
-
Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999;189(3):300-308 (Pubitemid 29489213)
-
(1999)
Journal of Pathology
, vol.189
, Issue.3
, pp. 300-308
-
-
Curran, S.1
Murray, G.I.2
-
10
-
-
0033618337
-
Matrix metalloproteinases
-
Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274(31):21491-21494
-
(1999)
J Biol Chem
, vol.274
, Issue.31
, pp. 21491-21494
-
-
Nagase, H.1
Woessner Jr., J.F.2
-
11
-
-
0031025218
-
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
-
DOI 10.1074/jbc.272.4.2446
-
Ohuchi E, Imai K, Fujii Y, et al. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272(4):2446-2451 (Pubitemid 27058534)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.4
, pp. 2446-2451
-
-
Ohuchi, E.1
Imai, K.2
Fujii, Y.3
Sato, H.4
Seiki, M.5
Okada, Y.6
-
12
-
-
0033605561
-
Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP
-
DOI 10.1074/jbc.274.13.8925
-
Pei D. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 1999;274(13):8925-8932 (Pubitemid 29164694)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.13
, pp. 8925-8932
-
-
Pei, D.1
-
13
-
-
0030019731
-
Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis
-
Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 1996;119(2):209-215 (Pubitemid 26063238)
-
(1996)
Journal of Biochemistry
, vol.119
, Issue.2
, pp. 209-215
-
-
Sato, H.1
Seiki, M.2
-
14
-
-
0037498559
-
Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer
-
DOI 10.1016/S0090-8258(03)00077-5
-
Tunuguntla R, Ripley D, Sang QX, et al. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 2003;89(3):453-459 (Pubitemid 36687792)
-
(2003)
Gynecologic Oncology
, vol.89
, Issue.3
, pp. 453-459
-
-
Tunuguntla, R.1
Ripley, D.2
Sang, Q.-X.A.3
Chegini, N.4
-
15
-
-
0031671855
-
Matrix metalloproteinase degradation of extracellular matrix: Biological consequences
-
DOI 10.1016/S0955-0674(98)80035-5
-
Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998;10(5):602-608 (Pubitemid 28477018)
-
(1998)
Current Opinion in Cell Biology
, vol.10
, Issue.5
, pp. 602-608
-
-
Shapiro, S.D.1
-
16
-
-
0036716282
-
Strategies for MMP inhibition in cancer: Innovations for the post-trial era
-
DOI 10.1038/nrc884
-
Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;2(9):657-672 (Pubitemid 37328917)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.9
, pp. 657-672
-
-
Overall, C.M.1
Lopez-Otin, C.2
-
17
-
-
0022382006
-
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
-
DOI 10.1038/318066a0
-
Docherty AJ, Lyons A, Smith BJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318(6041):66-69 (Pubitemid 16230337)
-
(1985)
Nature
, vol.318
, Issue.6041
, pp. 66-69
-
-
Docherty, A.J.P.1
Lyons, A.2
Smith, B.J.3
-
19
-
-
0029806813
-
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
-
DOI 10.1074/jbc.271.48.30375
-
Greene J, Wang M, Liu YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271(48):30375-30380 (Pubitemid 26404039)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.48
, pp. 30375-30380
-
-
Greene, J.1
Wang, M.2
Liu, Y.E.3
Raymond, L.A.4
Rosen, C.5
Shi, Y.E.6
-
20
-
-
0029019867
-
The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family
-
Erratum in: J Biol Chem 1996;271(5):2874
-
Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 1995;270(24):14313-8. Erratum in: J Biol Chem 1996;271(5):2874
-
(1995)
J Biol Chem
, vol.270
, Issue.24
, pp. 14313-14318
-
-
Apte, S.S.1
Olsen, B.R.2
Murphy, G.3
-
21
-
-
0031000957
-
Activation of progelatinase a and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase
-
Kolkenbrock H, Hecker-Kia A, Orgel D, et al. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol Chem 1997;378(2):71-76 (Pubitemid 27166039)
-
(1997)
Biological Chemistry
, vol.378
, Issue.2
, pp. 71-76
-
-
Kolkenbrock, H.1
Hecker-Kia, A.2
Orgel, D.3
Ulbrich, N.4
Will, H.5
-
22
-
-
0029959437
-
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1
-
DOI 10.1073/pnas.93.14.7069
-
Levi E, Fridman R, Miao HQ, et al. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA 1996;93(14):7069-7074 (Pubitemid 26243503)
-
(1996)
Proceedings of the National Academy of Sciences of the United States of America
, vol.93
, Issue.14
, pp. 7069-7074
-
-
Levi, E.1
Fridman, R.2
Miao, H.-Q.3
Ma, Y.-S.4
Yayon, A.5
Vlodavsky, I.6
-
23
-
-
0028485654
-
Processing of tumour necrosis factor-α precursor by metalloproteinases
-
DOI 10.1038/370555a0
-
Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 1994;370(6490):555-557 (Pubitemid 24264920)
-
(1994)
Nature
, vol.370
, Issue.6490
, pp. 555-557
-
-
Gearing, A.J.H.1
Beckett, P.2
Christodoulou, M.3
Churchill, M.4
Clements, J.5
Davidson, A.H.6
Drummond, A.H.7
Galloway, W.A.8
Gilbert, R.9
Gordon, J.L.10
Leber, T.M.11
Mangan, M.12
Miller, K.13
Nayee, P.14
Owen, K.15
Patel, S.16
Thomas, W.17
Wells, G.18
Wood, L.M.19
Wooley, K.20
more..
-
24
-
-
0031467314
-
Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
-
DOI 10.1074/jbc.272.50.31730
-
Suzuki M, Raab G, Moses MA, et al. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 1997;272(50):31730-31737 (Pubitemid 28013322)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.50
, pp. 31730-31737
-
-
Suzuki, M.1
Raab, G.2
Moses, M.A.3
Fernandez, C.A.4
Klagsbrun, M.5
-
25
-
-
0035500490
-
The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis
-
DOI 10.1016/S0962-8924(01)02122-5, PII S0962892401021225
-
Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001;11(11):S37-43 (Pubitemid 33001442)
-
(2001)
Trends in Cell Biology
, vol.11
, Issue.11
-
-
Chang, C.1
Werb, Z.2
-
26
-
-
0033380154
-
Matrix metalloproteinases in repair
-
Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999;7(6):423-432
-
(1999)
Wound Repair Regen
, vol.7
, Issue.6
, pp. 423-432
-
-
Parks, W.C.1
-
27
-
-
0027450757
-
Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
-
Rodgers WH, Osteen KG, Matrisian LM, et al. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 1993;168(1 Pt 1):253-260 (Pubitemid 23047649)
-
(1993)
American Journal of Obstetrics and Gynecology
, vol.168
, Issue.1
, pp. 253-260
-
-
Rodgers, W.H.1
Osteen, K.G.2
Matrisian, L.M.3
Navre, M.4
Giudice, L.G.5
Gorstein, F.6
-
28
-
-
0028049576
-
Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
-
Rodgers WH, Matrisian LM, Giudice LC, et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994;94(3):946-953
-
(1994)
J Clin Invest
, vol.94
, Issue.3
, pp. 946-953
-
-
Rodgers, W.H.1
Matrisian, L.M.2
Giudice, L.C.3
-
30
-
-
0026896029
-
The matrix-degrading metalloproteinases
-
Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14(7):455-463
-
(1992)
Bioessays
, vol.14
, Issue.7
, pp. 455-463
-
-
Matrisian, L.M.1
-
31
-
-
0028141232
-
Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation
-
Hampton AL, Salamonsen LA. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 1994;141(1):R1-3
-
(1994)
J Endocrinol
, vol.141
, Issue.1
-
-
Hampton, A.L.1
Salamonsen, L.A.2
-
32
-
-
0042862919
-
Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium
-
DOI 10.1095/biolreprod.103.015933
-
Goffin F, Munaut C, Frankenne F, et al. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod 2003;69(3):976-984 (Pubitemid 37064627)
-
(2003)
Biology of Reproduction
, vol.69
, Issue.3
, pp. 976-984
-
-
Goffin, F.1
Munaut, C.2
Frankenne, F.3
D'Hauterive, S.P.4
Beliard, A.5
Fridman, V.6
Nervo, P.7
Colige, A.8
Foidart, J.-M.9
-
33
-
-
33645312651
-
Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: A clinical-pathological correlation study
-
Graesslin O, Cortez A, Fauvet R, et al. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. Ann Oncol 2006;17(4):637-645
-
(2006)
Ann Oncol
, vol.17
, Issue.4
, pp. 637-645
-
-
Graesslin, O.1
Cortez, A.2
Fauvet, R.3
-
34
-
-
4444276289
-
Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer
-
DOI 10.1016/j.ygyno.2004.05.024, PII S0090825804003348
-
Pilka R, Norata GD, Domanski H, et al. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer. Gynecol Oncol 2004;94(3):661-670 (Pubitemid 39194458)
-
(2004)
Gynecologic Oncology
, vol.94
, Issue.3
, pp. 661-670
-
-
Pilka, R.1
Norata, G.D.2
Domanski, H.3
Andersson, C.4
Hansson, S.5
Eriksson, P.6
Casslen, B.7
-
35
-
-
0037635037
-
Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium
-
Pilka R, Whatling C, Domanski H, et al. Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium. Mol Hum Reprod 2003;9(5):271-277 (Pubitemid 36748830)
-
(2003)
Molecular Human Reproduction
, vol.9
, Issue.5-6
, pp. 271-277
-
-
Pilka, R.1
Whatling, C.2
Domanski, H.3
Hansson, S.4
Eriksson, P.5
Casslen, B.6
-
36
-
-
0034502797
-
Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium: Enhanced expression by endometrial adenocarcinomas is associated with low differentiation
-
Maatta M, Soini Y, Liakka A, et al. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 2000;114(3):402-411 (Pubitemid 33049676)
-
(2000)
American Journal of Clinical Pathology
, vol.114
, Issue.3
, pp. 402-411
-
-
Maatta, M.1
Soini, Y.2
Liakka, A.3
Autio-Harmainen, H.4
-
37
-
-
5044250714
-
Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26
-
A descriptive article concerning TIMP-4 and MMP-26
-
Pilka R, Domanski H, Hansson S, et al. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26. Mol Hum Reprod 2004;10(9):641-650 •• A descriptive article concerning TIMP-4 and MMP-26.
-
(2004)
Mol Hum Reprod
, vol.10
, Issue.9
, pp. 641-650
-
-
Pilka, R.1
Domanski, H.2
Hansson, S.3
-
38
-
-
0041334206
-
Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding
-
DOI 10.1016/S0015-0282(03)00797-0
-
Chegini N, Rhoton-Vlasak A, Williams RS. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. Fertil Steril 2003;80(3):564-570 (Pubitemid 37102867)
-
(2003)
Fertility and Sterility
, vol.80
, Issue.3
, pp. 564-570
-
-
Chegini, N.1
Rhoton-Vlasak, A.2
Williams, R.S.3
-
39
-
-
33748673747
-
Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition
-
DOI 10.1055/s-2006-948552
-
Curry TE Jr, Smith MF. Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition. Semin Reprod Med 2006;24(4):228-241 (Pubitemid 44387527)
-
(2006)
Seminars in Reproductive Medicine
, vol.24
, Issue.4
, pp. 228-241
-
-
Curry Jr., T.E.1
Smith, M.F.2
-
40
-
-
22844439757
-
Functions for proteinases in the ovulatory process
-
Ohnishi J, Ohnishi E, Shibuya H, Takahashi T. Functions for proteinases in the ovulatory process. Biochim Biophys Acta 2005;1751(1):95-109
-
(2005)
Biochim Biophys Acta
, vol.1751
, Issue.1
, pp. 95-109
-
-
Ohnishi, J.1
Ohnishi, E.2
Shibuya, H.3
Takahashi, T.4
-
41
-
-
0041352075
-
The matrix metalloproteinase system: Changes, regulation, and impact throughout the ovarian and uterine reproductive cycle
-
Probably the most well-written review article that can currently be found on the role of MMPs in the physiological processes involved in the reproductive cycle
-
Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003;24(4):428-465 •• Probably the most well-written review article that can currently be found on the role of MMPs in the physiological processes involved in the reproductive cycle.
-
(2003)
Endocr Rev
, vol.24
, Issue.4
, pp. 428-465
-
-
Curry Jr., T.E.1
Osteen, K.G.2
-
42
-
-
0035032124
-
Cyclic changes in the matrix metalloproteinase system in the ovary and uterus
-
Curry TE Jr, Osteen KG. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001;64(5):1285-1296
-
(2001)
Biol Reprod
, vol.64
, Issue.5
, pp. 1285-1296
-
-
Curry Jr., T.E.1
Osteen, K.G.2
-
43
-
-
0033041733
-
Changes in the cervical extracellular matrix during pregnancy and parturition
-
Winkler M, Rath W. Changes in the cervical extracellular matrix during pregnancy and parturition. J Perinat Med 1999;27(1):45-60 (Pubitemid 29145889)
-
(1999)
Journal of Perinatal Medicine
, vol.27
, Issue.1
, pp. 45-60
-
-
Winkler, M.1
Rath, W.2
-
44
-
-
54349116550
-
Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
-
Published online 30 September 2008, doi:10.1186/1477-7827-6-45
-
Becher N, Hein M, Uldbjerg N, Danielsen CC. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP. Reprod Biol Endocrinol 2008;6:45. Published online 30 September 2008, doi:10.1186/1477-7827-6-45
-
(2008)
Reprod Biol Endocrinol
, vol.6
, pp. 45
-
-
Becher, N.1
Hein, M.2
Uldbjerg, N.3
Danielsen, C.C.4
-
45
-
-
0037693895
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry
-
DOI 10.1161/01.RES.0000070112.80711.3D
-
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92(8):827-839 (Pubitemid 36542523)
-
(2003)
Circulation Research
, vol.92
, Issue.8
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
46
-
-
0032821995
-
Extracellular matrix degradation by metalloproteinases and central nervous system diseases
-
Lukes A, Mun-Bryce S, Lukes M, et al. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol 1999;19(3):267-284 (Pubitemid 29418895)
-
(1999)
Molecular Neurobiology
, vol.19
, Issue.3
, pp. 267-284
-
-
Lukes, A.1
Mun-Bryce, S.2
Lukes, M.3
Rosenberg, G.A.4
-
47
-
-
0033989425
-
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
-
Rooprai HK, Rucklidge GJ, Panou C, et al. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 2000;82(1):52-55 (Pubitemid 30008958)
-
(2000)
British Journal of Cancer
, vol.82
, Issue.1
, pp. 52-55
-
-
Rooprai, H.K.1
Rucklidge, G.J.2
Panou, C.3
Pilkington, G.J.4
-
48
-
-
0842332135
-
Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression
-
Torng PL, Mao TL, Chan WY, et al. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression. Gynecol Oncol 2004;92(2):559-567
-
(2004)
Gynecol Oncol
, vol.92
, Issue.2
, pp. 559-567
-
-
Torng, P.L.1
Mao, T.L.2
Chan, W.Y.3
-
49
-
-
0034488852
-
Interstitial collagenases as markers of tumor progression
-
Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6(12):4823-4830 (Pubitemid 32110426)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.12
, pp. 4823-4830
-
-
Brinckerhoff, C.E.1
Rutter, J.L.2
Benbow, U.3
-
50
-
-
0031724948
-
Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells
-
DOI 10.1210/jc.83.5.1721
-
Huang HY, Wen Y, Irwin JC, et al. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 1998;83(5):1721-1729 (Pubitemid 28501048)
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.5
, pp. 1721-1729
-
-
Huang, H.-Y.1
Wen, Y.2
Irwin, J.C.3
Kruessel, J.S.4
Soong, Y.-K.5
Polan, M.L.6
-
51
-
-
0027934326
-
Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1α and tumor necrosis factor-α
-
Rawdanowicz TJ, Hampton AL, Nagase H, et al. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 1994;79(2):530-536 (Pubitemid 24983154)
-
(1994)
Journal of Clinical Endocrinology and Metabolism
, vol.79
, Issue.2
, pp. 530-536
-
-
Rawdanowicz, T.J.1
Hampton, A.L.2
Nagase, H.3
Woolley, D.E.4
Salamonsen, L.A.5
-
52
-
-
0030885425
-
Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1α and its dual block by ovarian steroids
-
DOI 10.1073/pnas.94.19.10341
-
Singer CF, Marbaix E, Kokorine I, et al. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1α and its dual block by ovarian steroids. Proc Natl Acad Sci USA 1997;94(19):10341-10345 (Pubitemid 27407043)
-
(1997)
Proceedings of the National Academy of Sciences of the United States of America
, vol.94
, Issue.19
, pp. 10341-10345
-
-
Singer, C.F.1
Marbaix, E.2
Kokorine, I.3
Lemoine, P.4
Donnez, J.5
Eeckhout, Y.6
Courtoy, P.J.7
-
53
-
-
0029153128
-
Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium
-
Bruner KL, Rodgers WH, Gold LI, et al. Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995;92(16):7362-7366
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, Issue.16
, pp. 7362-7366
-
-
Bruner, K.L.1
Rodgers, W.H.2
Gold, L.I.3
-
54
-
-
0027333411
-
Tumor cell interactions with the extracellular matrix during invasion and metastasis
-
Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-573 (Pubitemid 2021155)
-
(1993)
ANNU.REV.CELL BIOL.
, vol.9
, pp. 541-573
-
-
Stetler-Stevenson, W.G.1
Aznavoorian, S.2
Liotta, L.A.3
-
55
-
-
34547103763
-
ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer
-
Monge M, Colas E, Doll A, et al. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res 2007;67(14):6753-6759
-
(2007)
Cancer Res
, vol.67
, Issue.14
, pp. 6753-6759
-
-
Monge, M.1
Colas, E.2
Doll, A.3
-
56
-
-
0030478724
-
Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
-
DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.0.CO;2-7
-
Iwasaka C, Tanaka K, Abe M, et al. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 1996;169(3):522-531 (Pubitemid 26426918)
-
(1996)
Journal of Cellular Physiology
, vol.169
, Issue.3
, pp. 522-531
-
-
Iwasaka, C.1
Tanaka, K.2
Abe, M.3
Sato, Y.4
-
57
-
-
0028908322
-
Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters
-
Higashino F, Yoshida K, Noumi T, et al. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 1995;10(7):1461-1463
-
(1995)
Oncogene
, vol.10
, Issue.7
, pp. 1461-1463
-
-
Higashino, F.1
Yoshida, K.2
Noumi, T.3
-
58
-
-
0025809504
-
The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins
-
Wasylyk C, Gutman A, Nicholson R, et al. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 1991;10(5):1127-1134 (Pubitemid 21905574)
-
(1991)
EMBO Journal
, vol.10
, Issue.5
, pp. 1127-1134
-
-
Wasylyk, C.1
Gutman, A.2
Nicholson, R.3
Wasylyk, B.4
-
59
-
-
0033757033
-
Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: Correlation to invasive potential
-
DOI 10.1006/gyno.2000.5944
-
Nishikawa A, Iwasaki M, Akutagawa N, et al. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Gynecol Oncol 2000;79(2):256-263 (Pubitemid 30822927)
-
(2000)
Gynecologic Oncology
, vol.79
, Issue.2
, pp. 256-263
-
-
Nishikawa, A.1
Iwasaki, M.2
Akutagawa, N.3
Manase, K.4
Yamashita, S.5
Endo, T.6
Kudo, R.7
-
60
-
-
0034936711
-
Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells
-
DOI 10.1006/gyno.2001.6229
-
Ueda M, Terai Y, Kumagai K, et al. Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 2001;82(1):162-166 (Pubitemid 32634970)
-
(2001)
Gynecologic Oncology
, vol.82
, Issue.1
, pp. 162-166
-
-
Ueda, M.1
Terai, Y.2
Kumagai, K.3
Ueki, K.4
Yamaguchi, H.5
Akise, D.6
Ueki, M.7
-
61
-
-
1642578258
-
Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin
-
DOI 10.1080/09513590310001651740
-
Prifti S, Lelle I, Zhong G, et al. Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin. Gynecol Endocrinol 2004;18(1):23-27 (Pubitemid 38134760)
-
(2004)
Gynecological Endocrinology
, vol.18
, Issue.1
, pp. 23-27
-
-
Prifti, S.1
Lelle, I.2
Zhong, G.3
Strowitzki, T.4
Rabe, T.5
-
62
-
-
0030969129
-
Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation
-
Salamonsen LA, Butt AR, Hammond FR, et al. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 1997;82(5):1409-1415
-
(1997)
J Clin Endocrinol Metab
, vol.82
, Issue.5
, pp. 1409-1415
-
-
Salamonsen, L.A.1
Butt, A.R.2
Hammond, F.R.3
-
63
-
-
0030030666
-
Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle
-
Irwin JC, Kirk D, Gwatkin RB, et al. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 1996;97(2):438-447 (Pubitemid 26039408)
-
(1996)
Journal of Clinical Investigation
, vol.97
, Issue.2
, pp. 438-447
-
-
Irwin, J.C.1
Kirk, D.2
Gwatkin, R.B.L.3
Navre, M.4
Cannon, P.5
Giudice, L.C.6
-
64
-
-
0034824366
-
Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro
-
DOI 10.1006/gyno.2001.6294
-
Park DW, Ryu HS, Choi DS, et al. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro. Gynecol Oncol 2001;82(3):442-449 (Pubitemid 32826442)
-
(2001)
Gynecologic Oncology
, vol.82
, Issue.3
, pp. 442-449
-
-
Park, D.-W.1
Ryu, H.-S.2
Choi, D.-S.3
Park, Y.-H.4
Chang, K.-H.5
Min, C.K.6
-
65
-
-
3242756950
-
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: Relationship to estrogen and progesterone receptor status
-
Cioppi F, Simi L, Luciani P, et al. Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. Oncol Rep 2004;11(2):427-433
-
(2004)
Oncol Rep
, vol.11
, Issue.2
, pp. 427-433
-
-
Cioppi, F.1
Simi, L.2
Luciani, P.3
-
66
-
-
0036681322
-
Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-α gene in endometrial carcinoma cells
-
Mizumoto H, Saito T, Ashihara K, et al. Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-α gene in endometrial carcinoma cells. Int J Cancer 2002;100(4):401-406
-
(2002)
Int J Cancer
, vol.100
, Issue.4
, pp. 401-406
-
-
Mizumoto, H.1
Saito, T.2
Ashihara, K.3
-
67
-
-
2442649948
-
Overexpressed progesterone receptor form B inhibit invasive activity suppressing matrix metalloproteinases in endometrial carcinoma cells
-
DOI 10.1016/j.canlet.2003.12.017, PII S0304383504000217
-
Saito T, Mizumoto H, Tanaka R, et al. Overexpressed progesterone receptor form B inhibit invasive activity suppressing matrix metalloproteinases in endometrial carcinoma cells. Cancer Lett 2004;209(2):237-243 (Pubitemid 38670494)
-
(2004)
Cancer Letters
, vol.209
, Issue.2
, pp. 237-243
-
-
Saito, T.1
Mizumoto, H.2
Tanaka, R.3
Satohisa, S.4
Adachi, K.5
Horie, M.6
Kudo, R.7
-
68
-
-
0037222089
-
Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture
-
Park YH, Ryu HS, Choi DS, et al. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int J Gynecol Cancer 2003;13(1):53-60
-
(2003)
Int J Gynecol Cancer
, vol.13
, Issue.1
, pp. 53-60
-
-
Park, Y.H.1
Ryu, H.S.2
Choi, D.S.3
-
69
-
-
33748889930
-
Localization of matrix metalloproteinase MMP-2 to the cell surface by interaction with integral αvβ3
-
Brooks PC, Stromblad S, Sanders LC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996;85(5):683-9362 (Pubitemid 126800892)
-
(1996)
FASEB Journal
, vol.10
, Issue.6
-
-
Brooks, P.C.1
Stromblad, S.2
Sanders, L.3
Vonschalscha, T.L.4
Amies, R.T.5
Ouigley, T.P.6
Cheresh, P.A.7
-
70
-
-
44349085988
-
Fibrinolysis: The key to new pathogenic mechanisms
-
DOI 10.2174/092986708783955455
-
Zorio E, Gilabert-Estelles J, Espana F, et al. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 2008;15(9):923-929 (Pubitemid 351736413)
-
(2008)
Current Medicinal Chemistry
, vol.15
, Issue.9
, pp. 923-929
-
-
Zorio, E.1
Gilabert-Estelles, J.2
Espana, F.3
Ramon, L.A.4
Cosin, R.5
Estelles, A.6
-
71
-
-
0022555838
-
Biochemical interactions of tumor cells with the basement membrane
-
Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986;55:1037-1057 (Pubitemid 16070794)
-
(1986)
Annual Review of Biochemistry
, vol.VOL. 55
, pp. 1037-1057
-
-
Liotta, L.A.1
Rao, C.N.2
Wewer, U.M.3
-
72
-
-
0034472617
-
Matrix metalloproteinases in tumor invasion and metastasis
-
DOI 10.1006/scbi.2000.0379
-
Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000;10(6):415-433 (Pubitemid 32181912)
-
(2000)
Seminars in Cancer Biology
, vol.10
, Issue.6
, pp. 415-433
-
-
Stamenkovic, I.1
-
73
-
-
0034532365
-
Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential
-
DOI 10.1007/s004280000261
-
Mueller J, Brebeck B, Schmalfeldt B, et al. Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential. Virchows Arch 2000;437(6):618-624 (Pubitemid 32003092)
-
(2000)
Virchows Archiv
, vol.437
, Issue.6
, pp. 618-624
-
-
Mueller, J.1
Brebeck, B.2
Schmalfeldt, B.3
Kuhn, W.4
Graeff, H.5
Hofler, H.6
-
74
-
-
36448962792
-
Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer
-
DOI 10.1159/000110426
-
Sillanpaa S, Anttila M, Suhonen K, et al. Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol 2007;28(5):280-289 (Pubitemid 350165834)
-
(2007)
Tumor Biology
, vol.28
, Issue.5
, pp. 280-289
-
-
Sillanpaa, S.1
Anttila, M.2
Suhonen, K.3
Hamalainen, K.4
Turpeenniemi-Hujanen, T.5
Puistola, U.6
Tammi, M.7
Sironen, R.8
Saarikoski, S.9
Kosma, V.-M.10
-
75
-
-
0032871733
-
Gelatinase A-immunoreactive protein in ovarian lesions - Prognostic value in epithelial ovarian cancer
-
DOI 10.1006/gyno.1999.5533
-
Westerlund A, Apaja-Sarkkinen M, Hoyhtya M, et al. Gelatinase A-immunoreactive protein in ovarian lesions - prognostic value in epithelial ovarian cancer. Gynecol Oncol 1999;75(1):91-98 (Pubitemid 29477808)
-
(1999)
Gynecologic Oncology
, vol.75
, Issue.1
, pp. 91-98
-
-
Westerlund, A.1
Apaja-Sarkkinen, M.2
Hoyhtya, M.3
Puistola, U.4
Turpeenniemi-Hujanen, T.5
-
76
-
-
0029552497
-
Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: Clinical and prognostic implications
-
Garzetti GG, Ciavattini A, Lucarini G, et al. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications. Anticancer Res 1995;15(6B):2799-2804 (Pubitemid 26095103)
-
(1995)
Anticancer Research
, vol.15
, Issue.6 B
, pp. 2799-2804
-
-
Garzetti, G.G.1
Ciavattini, A.2
Lucarini, G.3
Goteri, G.4
De Nictolis, M.5
Garbisa, S.6
Masiero, L.7
Romanini, C.8
Graziella, B.9
-
77
-
-
0036197006
-
Shed membrane fragment-associated markers for endometrial and ovarian cancers
-
DOI 10.1006/gyno.2001.6551
-
Taylor DD, Lyons KS, Gercel-Taylor C. Shed membrane fragment-associated markers for endometrial and ovarian cancers. Gynecol Oncol 2002;84(3):443-448 (Pubitemid 34211873)
-
(2002)
Gynecologic Oncology
, vol.84
, Issue.3
, pp. 443-448
-
-
Taylor, D.D.1
Lyons, K.S.2
Gercel-Taylor, C.3
-
78
-
-
41849105806
-
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
-
Kenny HA, Kaur S, Coussens LM, et al. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008;118(4):1367-1379
-
(2008)
J Clin Invest
, vol.118
, Issue.4
, pp. 1367-1379
-
-
Kenny, H.A.1
Kaur, S.2
Coussens, L.M.3
-
79
-
-
0028178968
-
Expression and activity of MMPS and their regulators in ovarian cancer
-
DOI 10.1002/ijc.2910580110
-
Naylor MS, Stamp GW, Davies BD, et al. Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 1994;58(1):50-56 (Pubitemid 24213969)
-
(1994)
International Journal of Cancer
, vol.58
, Issue.1
, pp. 50-56
-
-
Naylor, M.S.1
Stamp, G.W.2
Davies, B.D.3
Balkwill, F.R.4
-
80
-
-
49649098028
-
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells
-
Cowden Dahl KD, Symowicz J, Ning Y, et al. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells. Cancer Res 2008;68(12):4606-4613
-
(2008)
Cancer Res
, vol.68
, Issue.12
, pp. 4606-4613
-
-
Cowden Dahl, K.D.1
Symowicz, J.2
Ning, Y.3
-
81
-
-
0036142697
-
Activated matrix metalloproteinase-2 - A potential marker of prognosis for epithelial ovarian cancer
-
DOI 10.1006/gyno.2001.6477
-
Wu X, Li H, Kang L, et al. Activated matrix metalloproteinase-2-a potential marker of prognosis for epithelial ovarian cancer. Gynecol Oncol 2002;84(1):126-134 (Pubitemid 34056478)
-
(2002)
Gynecologic Oncology
, vol.84
, Issue.1
, pp. 126-134
-
-
Wu, X.1
Li, H.2
Kang, L.3
Li, L.4
Wang, W.5
Shan, B.6
-
82
-
-
58149250998
-
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer
-
Acar A, Onan A, Coskun U, et al. Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer. Med Oncol 2008;25(3):279-283
-
(2008)
Med Oncol
, vol.25
, Issue.3
, pp. 279-283
-
-
Acar, A.1
Onan, A.2
Coskun, U.3
-
83
-
-
58149483748
-
Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma
-
Adley BP, Gleason KJ, Yang XJ, et al. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol 2009;112(2):319-324
-
(2009)
Gynecol Oncol
, vol.112
, Issue.2
, pp. 319-324
-
-
Adley, B.P.1
Gleason, K.J.2
Yang, X.J.3
-
84
-
-
33644832165
-
Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome
-
DOI 10.1210/jc.2005-0648
-
Lewandowski KC, Komorowski J, O'Callaghan CJ, et al. Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91(3):1173-1177 (Pubitemid 43357797)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.3
, pp. 1173-1177
-
-
Lewandowski, K.C.1
Komorowski, J.2
O'Callaghan, C.J.3
Tan, B.K.4
Chen, J.5
Prelevic, G.M.6
Randeva, H.S.7
-
85
-
-
45949092504
-
Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1
-
DOI 10.1080/09513590802056995, PII 793697597
-
Liu B, Cai LY, Lv HM, et al. Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1. Gynecol Endocrinol 2008;24(5):285-288 (Pubitemid 351891659)
-
(2008)
Gynecological Endocrinology
, vol.24
, Issue.5
, pp. 285-288
-
-
Liu, B.1
Cai, L.-Y.2
Lv, H.-M.3
Xia, L.4
Zhang, Y.-J.5
Zhang, H.-X.6
Guan, Y.-M.7
-
86
-
-
0033762457
-
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
-
DOI 10.1023/A:1006723011835
-
Davidson B, Goldberg I, Gotlieb WH, et al. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis 1999;17(10):799-808 (Pubitemid 30823042)
-
(1999)
Clinical and Experimental Metastasis
, vol.17
, Issue.10
, pp. 799-808
-
-
Davidson, B.1
Goldberg, I.2
Gotlieb, W.H.3
Kopolovic, J.4
Ben-Baruch, G.5
Nesland, J.M.6
Berner, A.7
Bryne, M.8
Reich, R.9
-
87
-
-
0031909775
-
MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts
-
DOI 10.1016/S0046-8177(98)90226-X
-
Afzal S, Lalani EN, Poulsom R, et al. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998;29(2):155-165 (Pubitemid 28099511)
-
(1998)
Human Pathology
, vol.29
, Issue.2
, pp. 155-165
-
-
Afzal, S.1
Lalani, E.-N.2
Poulsom, R.3
Stubbs, A.4
Rowlinson, G.5
Sato, H.6
Seiki, M.7
Stamp, G.W.H.8
-
88
-
-
59049090760
-
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2
-
Brun JL, Cortez A, Commo F, et al. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. Int J Oncol 2008;33(6):1239-1246
-
(2008)
Int J Oncol
, vol.33
, Issue.6
, pp. 1239-1246
-
-
Brun, J.L.1
Cortez, A.2
Commo, F.3
-
89
-
-
0038548574
-
Membrane-associated MMP-2 in human cervical cancer
-
DOI 10.1615/JEnvPathToxOncol.v22.i2.20
-
Mitra A, Chakrabarti J, Chattopadhyay N, et al. Membrane-associated MMP-2 in human cervical cancer. J Environ Pathol Toxicol Oncol 2003;22(2):93-100 (Pubitemid 36750161)
-
(2003)
Journal of Environmental Pathology, Toxicology and Oncology
, vol.22
, Issue.2
, pp. 93-100
-
-
Mitra, A.1
Chakrabarti, J.2
Chattopadhyay, N.3
Chatterjee, A.4
-
90
-
-
33751261895
-
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells
-
DOI 10.1158/0008-5472.CAN-06-2496
-
Yang EV, Sood AK, Chen M, et al. Norepinephrine up-regulates the expression of vascular endothelial factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66(21):10357- 10364 (Pubitemid 44799755)
-
(2006)
Cancer Research
, vol.66
, Issue.21
, pp. 10357-10364
-
-
Yang, E.V.1
Sood, A.K.2
Chen, M.3
Li, Y.4
Eubank, T.D.5
Marsh, C.B.6
Jewell, S.7
Flavahan, N.A.8
Morrison, C.9
Yeh, P.-E.10
Lemeshow, S.11
Glaser, R.12
-
91
-
-
31544465011
-
Stress hormone-mediated invasion of ovarian cancer cells
-
DOI 10.1158/1078-0432.CCR-05-1698
-
Sood AK, Bhatty R, Kamat AA, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006;12(2):369-375 (Pubitemid 43166123)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.2
, pp. 369-375
-
-
Sood, A.K.1
Bhatty, R.2
Kamat, A.A.3
Landen, C.N.4
Han, L.5
Thaker, P.H.6
Li, Y.7
Gershenson, D.M.8
Lutgendorf, S.9
Cole, S.W.10
-
92
-
-
0037139421
-
Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas
-
DOI 10.1002/ijc.10193
-
Ueda M, Terai Y, Yamashita Y, et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer 2002;98(3):335-343 (Pubitemid 34188675)
-
(2002)
International Journal of Cancer
, vol.98
, Issue.3
, pp. 335-343
-
-
Ueda, M.1
Terai, Y.2
Yamashita, Y.3
Kumagai, K.4
Ueki, K.5
Yamaguchi, H.6
Akise, D.7
Hung, Y.-C.8
Ueki, M.9
-
93
-
-
0029921025
-
Recurrence patterns in locally advanced cervical carcinoma: Role of nodal status and 72-kDa metalloproteinase index
-
DOI 10.1006/gyno.1996.0101
-
Garzetti GG, Ciavattini A, Lucarini G, et al. Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72-kDa metalloproteinase index. Gynecol Oncol 1996;61(1):83-89 (Pubitemid 26108535)
-
(1996)
Gynecologic Oncology
, vol.61
, Issue.1
, pp. 83-89
-
-
Garzetti, G.G.1
Ciavattini, A.2
Lucarini, G.3
Goteri, G.4
De Nictolis, M.5
Romanini, C.6
Biagini, G.7
-
94
-
-
17444372448
-
Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix
-
Nasr M, Ayyad SB, El-Lamie IK, et al. Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol 2005;26(2):199-202 (Pubitemid 40546531)
-
(2005)
European Journal of Gynaecological Oncology
, vol.26
, Issue.2
, pp. 199-202
-
-
Mohamed Nasr, M.A.1
Ayyad, S.B.2
El-Lamie, I.K.I.3
Mikhail, M.Y.4
-
95
-
-
0037312532
-
Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix
-
Asha Nair S, Karunagaran D, Nair MB, et al. Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix. J Cancer Res Clin Oncol 2003;129(2):123-131 (Pubitemid 36470094)
-
(2003)
Journal of Cancer Research and Clinical Oncology
, vol.129
, Issue.2
, pp. 123-131
-
-
Nair, S.A.1
Karunagaran, D.2
Nair, M.B.3
Sudhakaran, P.R.4
-
96
-
-
2542471332
-
Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma
-
DOI 10.1016/j.ajog.2003.12.017
-
Gaiotto MA, Focchi J, Ribalta JL, et al. Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma. Am J Obstet Gynecol 2004;190(5):1278-1282 (Pubitemid 38692209)
-
(2004)
American Journal of Obstetrics and Gynecology
, vol.190
, Issue.5
, pp. 1278-1282
-
-
Gaiotto, M.A.M.1
Focchi, J.2
Ribalta, J.L.C.3
Stavale, J.N.4
Baracat, E.C.5
Lima, G.R.6
Guerreiro Da Silva, I.D.C.7
-
97
-
-
15244350530
-
Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: Relationship with prognosis
-
Ahmed MI, Salahy EE, Tawfiq H, et al. Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: relationship with prognosis. Dis Markers 2004;20(6):333-343 (Pubitemid 40385314)
-
(2004)
Disease Markers
, vol.20
, Issue.6
, pp. 333-343
-
-
Ahmed, M.I.1
Salahy, E.-E.2
Tawfiq, H.3
Khalifa, A.4
Hassan, M.M.5
-
98
-
-
0033019235
-
MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - A clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
-
DOI 10.1006/gyno.1999.5381
-
Davidson B, Goldberg I, Kopolovic J, et al. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 1999;73(3):372-382 (Pubitemid 29272858)
-
(1999)
Gynecologic Oncology
, vol.73
, Issue.3
, pp. 372-382
-
-
Davidson, B.1
Goldberg, I.2
Kopolovic, J.3
Lerner-Geva, L.4
Gotlieb, W.H.5
Ben-Baruch, G.6
Reich, R.7
-
99
-
-
0036500250
-
Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion
-
DOI 10.1002/cncr.10355
-
Di Nezza LA, Misajon A, Zhang J, et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 2002;94(5):1466-1475 •• An outstanding paper on MMPs in endometrial carcinoma. (Pubitemid 34213290)
-
(2002)
Cancer
, vol.94
, Issue.5
, pp. 1466-1475
-
-
Di Nezza, L.A.1
Misajon, A.2
Zhang, J.3
Jobling, T.4
Quinn, M.A.5
Ostor, A.G.6
Nie, G.7
Lopata, A.8
Salamonsen, L.A.9
-
100
-
-
0038703340
-
MT1-MMP and MMP-7 in invasion and metastasis of human cancers
-
DOI 10.1023/A:1023039230052
-
Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003;22(2-3):145-152 (Pubitemid 36561054)
-
(2003)
Cancer and Metastasis Reviews
, vol.22
, Issue.2-3
, pp. 145-152
-
-
Shiomi, T.1
Okada, Y.2
-
101
-
-
0032836038
-
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma
-
DOI 10.1046/j.1365-2362.1999.00532.x
-
Iurlaro M, Loverro G, Vacca A, et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur J Clin Invest 1999;29(9):793-801 (Pubitemid 29425521)
-
(1999)
European Journal of Clinical Investigation
, vol.29
, Issue.9
, pp. 793-801
-
-
Iurlaro, M.1
Loverro, G.2
Vacca, A.3
Cormio, G.4
Ribatti, O.5
Minischetti, M.6
Ria, R.7
Bruno, M.8
Selvaggi, L.9
-
102
-
-
0030914588
-
Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma
-
Inoue Y, Abe K, Obata K, et al. Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma. J Obstet Gynaecol Res 1997;23(2):139-145 (Pubitemid 27220052)
-
(1997)
Journal of Obstetrics and Gynaecology Research
, vol.23
, Issue.2
, pp. 139-145
-
-
Inoue, Y.1
Abe, K.2
Obata, K.3
Yoshioka, T.4
Ohmura, G.5
Doh, K.6
Yamamoto, K.7
Hoshiai, H.8
Noda, K.9
-
103
-
-
33749152996
-
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions
-
DOI 10.1111/j.1525-1438.2006.00717.x
-
Graesslin O, Cortez A, Uzan C, et al. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer 2006;16(5):1911-1917 (Pubitemid 44470055)
-
(2006)
International Journal of Gynecological Cancer
, vol.16
, Issue.5
, pp. 1911-1917
-
-
Graesslin, O.1
Cortez, A.2
Uzan, C.3
Birembaut, P.4
Quereux, C.5
Darai, E.6
-
104
-
-
34250868438
-
Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma
-
Karahan N, Guney M, Baspinar S, et al. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J Gynaecol Oncol 2007;28(3):184-188 (Pubitemid 46985638)
-
(2007)
European Journal of Gynaecological Oncology
, vol.28
, Issue.3
, pp. 184-188
-
-
Karahan, N.1
Guney, M.2
Baspinar, S.3
Oral, B.4
Kapucuoglu, N.5
Mungan, T.6
-
105
-
-
4444291637
-
Gelatinases a and B (MMP-2 and MMP-9) in endometrial cancer - MMP-9 correlates to the grade and the stage
-
DOI 10.1016/j.ygyno.2004.06.028, PII S0090825804004317
-
Aglund K, Rauvala M, Puistola U, et al. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol 2004;94(3):699-704 (Pubitemid 39194463)
-
(2004)
Gynecologic Oncology
, vol.94
, Issue.3
, pp. 699-704
-
-
Aglund, K.1
Rauvala, M.2
Puistola, U.3
Angstrom, T.4
Turpeenniemi-Hujanen, T.5
Zackrisson, B.6
Stendahl, U.7
-
106
-
-
0042123774
-
Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity
-
DOI 10.1016/S0090-8258(03)00328-7
-
Lopata A, Agresta F, Quinn MA, et al. Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity. Gynecol Oncol 2003;90(2):318-324 (Pubitemid 36952020)
-
(2003)
Gynecologic Oncology
, vol.90
, Issue.2
, pp. 318-324
-
-
Lopata, A.1
Agresta, F.2
Quinn, M.A.3
Smith, C.4
Ostor, A.G.5
Salamonsen, L.A.6
-
107
-
-
0029738845
-
Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer
-
Mutter GL, Boynton KA, Faquin WC, et al. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer. Cancer Res 1996;56(19):4483-4486
-
(1996)
Cancer Res
, vol.56
, Issue.19
, pp. 4483-4486
-
-
Mutter, G.L.1
Boynton, K.A.2
Faquin, W.C.3
-
108
-
-
0032774472
-
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer
-
Moser PL, Hefler L, Tempfer C, et al. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer. Anticancer Res 1999;19(3B):2365-2367 (Pubitemid 29392548)
-
(1999)
Anticancer Research
, vol.19
, Issue.3 B
, pp. 2365-2367
-
-
Moser, P.L.1
Hefler, L.2
Tempfer, C.3
Neunteufel, W.4
Kieback, D.G.5
Gitsch, G.6
-
109
-
-
33846030501
-
MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma
-
DOI 10.1016/j.ygyno.2006.08.006, PII S0090825806006147
-
Honkavuori M, Talvensaari-Mattila A, Soini Y, et al. MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma. Gynecol Oncol 2007;104(1):217-221 (Pubitemid 46054133)
-
(2007)
Gynecologic Oncology
, vol.104
, Issue.1
, pp. 217-221
-
-
Honkavuori, M.1
Talvensaari-Mattila, A.2
Soini, Y.3
Turpeenniemi-Hujanen, T.4
Santala, M.5
-
110
-
-
34447505972
-
Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma
-
DOI 10.1016/j.prp.2007.03.008, PII S0344033807000817
-
Yang X, Dong Y, Zhao J, et al. Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma. Pathol Res Pract 2007;203(7):499-505 (Pubitemid 47065354)
-
(2007)
Pathology Research and Practice
, vol.203
, Issue.7
, pp. 499-505
-
-
Yang, X.1
Dong, Y.2
Zhao, J.3
Sun, H.4
Deng, Y.5
Fan, J.6
Yan, Q.7
-
111
-
-
0033595649
-
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas
-
Ueno H, Yamashita K, Azumano I, et al. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas. Int J Cancer 1999;84(5):470-477
-
(1999)
Int J Cancer
, vol.84
, Issue.5
, pp. 470-477
-
-
Ueno, H.1
Yamashita, K.2
Azumano, I.3
-
112
-
-
33644692295
-
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis
-
Misugi F, Sumi T, Okamoto E, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis. Int J Mol Med 2005;16(4):541-546
-
(2005)
Int J Mol Med
, vol.16
, Issue.4
, pp. 541-546
-
-
Misugi, F.1
Sumi, T.2
Okamoto, E.3
-
113
-
-
0028650295
-
Matrix metalloproteinase gene expression
-
Matrisian LM. Matrix metalloproteinase gene expression. Ann NY Acad Sci 1994;732:42-50
-
(1994)
Ann NY Acad Sci
, vol.732
, pp. 42-50
-
-
Matrisian, L.M.1
-
114
-
-
49649096620
-
MMP-2, TIMP-1, E-cadherin, and β-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium
-
Shaco-Levy R, Sharabi S, Piura B, et al. MMP-2, TIMP-1, E-cadherin, and β-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium. Acta Obstet Gynecol Scand 2008;87(8):868-874
-
(2008)
Acta Obstet Gynecol Scand
, vol.87
, Issue.8
, pp. 868-874
-
-
Shaco-Levy, R.1
Sharabi, S.2
Piura, B.3
-
115
-
-
55749084920
-
High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma
-
Honkavuori M, Talvensaari-Mattila A, Puistola U, et al. High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma. Anticancer Res 2008;28(5A):2715-2719
-
(2008)
Anticancer Res
, vol.28
, Issue.5 A
, pp. 2715-2719
-
-
Honkavuori, M.1
Talvensaari-Mattila, A.2
Puistola, U.3
-
116
-
-
0242365355
-
Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp
-
DOI 10.1016/S0301-2115(03)00244-6
-
Inagaki N, Ung L, Otani T, et al. Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol 2003;111(2):197-203 (Pubitemid 37338741)
-
(2003)
European Journal of Obstetrics Gynecology and Reproductive Biology
, vol.111
, Issue.2
, pp. 197-203
-
-
Inagaki, N.1
Ung, L.2
Otani, T.3
Wilkinson, D.4
Lopata, A.5
-
117
-
-
43049121273
-
Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps
-
Erdemoglu E, Guney M, Karahan N, et al. Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas 2008;59(3):268-274
-
(2008)
Maturitas
, vol.59
, Issue.3
, pp. 268-274
-
-
Erdemoglu, E.1
Guney, M.2
Karahan, N.3
-
118
-
-
0037217258
-
Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma
-
DOI 10.1002/cncr.11030
-
Isaka K, Nishi H, Nakai H, et al. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer 2003;97(1):79-89 (Pubitemid 36033866)
-
(2003)
Cancer
, vol.97
, Issue.1
, pp. 79-89
-
-
Isaka, K.1
Nishi, H.2
Nakai, H.3
Nakada, T.4
Feng Li, Y.5
Ebihara, Y.6
Takayama, M.7
Nozawa, S.8
Mizusawa, Y.9
-
119
-
-
0034283015
-
Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity
-
Uria JA, Lopez-Otin C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 2000;60(17):4745-4751 (Pubitemid 30701482)
-
(2000)
Cancer Research
, vol.60
, Issue.17
, pp. 4745-4751
-
-
Uria, J.A.1
Lopez-Otin, C.2
-
120
-
-
0034686076
-
Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme
-
DOI 10.1074/jbc.275.20.14809
-
Stracke JO, Hutton M, Stewart M, et al. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J Biol Chem 2000;275(20):14809- 14816 (Pubitemid 30337192)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.20
, pp. 14809-14816
-
-
Stracke, J.O.1
Hutton, M.2
Stewart, M.3
Pendas, A.M.4
Smith, B.5
Lopez-Otin, C.6
Murphy, G.7
Knauper, V.8
-
121
-
-
0036309737
-
Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3
-
Zhang J, Cao YJ, Zhao YG, et al. Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod 2002;8(7):659-666 (Pubitemid 34752927)
-
(2002)
Molecular Human Reproduction
, vol.8
, Issue.7
, pp. 659-666
-
-
Zhang, J.1
Cao, Y.-J.2
Zhao, Y.-G.3
Sang, Q.-X.A.4
Duan, E.-K.5
-
122
-
-
0028827415
-
Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form
-
Tamakoshi K, Kikkawa F, Nawa A, et al. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer 1995;76(12):2565-2571
-
(1995)
Cancer
, vol.76
, Issue.12
, pp. 2565-2571
-
-
Tamakoshi, K.1
Kikkawa, F.2
Nawa, A.3
-
123
-
-
0031228307
-
Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle
-
Zhang J, Salamonsen LA. Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod 1997;3(9):735-741
-
(1997)
Mol Hum Reprod
, vol.3
, Issue.9
, pp. 735-741
-
-
Zhang, J.1
Salamonsen, L.A.2
-
124
-
-
0027407101
-
Stability analysis of latent and active 72-kDa type IV collagenase: The role of tissue inhibitor of metalloproteinases-2 (TIMP-2)
-
Kleiner DE Jr, Tuuttila A, Tryggvason K, et al. Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 1993;32(6):1583-1592 (Pubitemid 23077567)
-
(1993)
Biochemistry
, vol.32
, Issue.6
, pp. 1583-1592
-
-
Kleiner Jr., D.E.1
Tuuttila, A.2
Tryggvason, K.3
Stetler-Stevenson, W.G.4
-
125
-
-
0033966536
-
Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: Enzymes coordinately expressed in human endometrium
-
Zhang J, Hampton AL, Nie G, et al. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol Reprod 2000;62(1):85-94 (Pubitemid 30013472)
-
(2000)
Biology of Reproduction
, vol.62
, Issue.1
, pp. 85-94
-
-
Zhang, J.1
Hampton, A.L.2
Nie, G.3
Salamonsen, L.A.4
-
126
-
-
9244225106
-
72-KiloDalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors of the ovary: A clinicopathologic, immunohistochemical, and serological study
-
De Nictolis M, Garbisa S, Lucarini G, et al. 72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and Serological study. Int J Gynecol Pathol 1996;15(2):102-109 (Pubitemid 26113857)
-
(1996)
International Journal of Gynecological Pathology
, vol.15
, Issue.2
, pp. 102-109
-
-
De Nictolis, M.1
Garbisa, S.2
Lucarini, G.3
Goteri, G.4
Masiero, L.5
Ciavattini, A.6
Garzetti, G.G.7
Stetler-Stevenson, W.G.8
Fabris, G.9
Biagini, G.10
Prat, J.11
-
127
-
-
0029760197
-
Increased serum 72 KDa metalloproteinase in serous ovarian tumors: Comparison with CA 125
-
Garzetti GG, Ciavattini A, Lucarini G, et al. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125. Anticancer Res 1996;16(4A):2123-2127 (Pubitemid 26270736)
-
(1996)
Anticancer Research
, vol.16
, Issue.4 A
, pp. 2123-2127
-
-
Garzetti, G.G.1
Ciavattini, A.2
Lucarini, G.3
Goteri, G.4
Romanini, C.5
Biagini, G.6
-
128
-
-
28044458735
-
Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor
-
Rauvala M, Puistola U, Turpeenniemi-Hujanen T. Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor. Gynecol Oncol 2005;99(3):656-663
-
(2005)
Gynecol Oncol
, vol.99
, Issue.3
, pp. 656-663
-
-
Rauvala, M.1
Puistola, U.2
Turpeenniemi-Hujanen, T.3
-
129
-
-
33845948559
-
The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer
-
Rauvala M, Turpeenniemi-Hujanen T, Puistola U. The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer. Anticancer Res 2006;26(6C):4779-4784 (Pubitemid 46032113)
-
(2006)
Anticancer Research
, vol.26
, Issue.6 C
, pp. 4779-4784
-
-
Rauvala, M.1
Turpeenniemi-Hujanen, T.2
Puistola, U.3
-
130
-
-
0034279752
-
Prognostic value of serum MMP-2 level in uterine cancer affected women
-
Adamiak A, Postawski K, Semczuk A, et al. Prognostic value of serum MMP-2 level in uterine cancer affected women. Ginekol Pol 2000;71(9):1198-1201
-
(2000)
Ginekol Pol
, vol.71
, Issue.9
, pp. 1198-1201
-
-
Adamiak, A.1
Postawski, K.2
Semczuk, A.3
-
131
-
-
0042624791
-
Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies
-
DOI 10.1016/S0090-8258(03)00334-2
-
Bazzett LB, Magnus M, Taylor DD, et al. Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies. Gynecol Oncol 2003;90(2):435-442 (Pubitemid 36952041)
-
(2003)
Gynecologic Oncology
, vol.90
, Issue.2
, pp. 435-442
-
-
Bazzett, L.B.1
Magnus, M.2
Taylor, D.D.3
Gercel-Taylor, C.4
-
132
-
-
0034122601
-
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers
-
Sier CF, Casetta G, Verheijen JH, et al. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. Clin Cancer Res 2000;6(6):2333-2340 (Pubitemid 30399200)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.6
, pp. 2333-2340
-
-
Sier, C.F.M.1
Casetta, G.2
Verheijen, J.H.3
Tizzani, A.4
Agape, V.5
Kos, J.6
Blasi, F.7
Hanemaaijer, R.8
-
133
-
-
0035318082
-
Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma
-
Gerhards S, Jung K, Koenig F, et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 2001;57(4):675-679
-
(2001)
Urology
, vol.57
, Issue.4
, pp. 675-679
-
-
Gerhards, S.1
Jung, K.2
Koenig, F.3
-
134
-
-
0030723230
-
Matrix metalloproteinase inhibitors: Present achievements and future prospects
-
DOI 10.1023/A:1005855905442
-
Denis LJ, Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest New Drugs 1997;15(3):175-185 (Pubitemid 27453872)
-
(1997)
Investigational New Drugs
, vol.15
, Issue.3
, pp. 175-185
-
-
Denis, L.J.1
Verweij, J.2
-
135
-
-
0029188425
-
Matrix metalloproteinase inhibitors: A novel class of anticancer agents
-
Brown PD. Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv Enzyme Regul 1995;35:293-301
-
(1995)
Adv Enzyme Regul
, vol.35
, pp. 293-301
-
-
Brown, P.D.1
-
136
-
-
31344458952
-
Structure and function of matrix metalloproteinases and TIMPs
-
DOI 10.1016/j.cardiores.2005.12.002, PII S0008636305005651
-
Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69(3):562-573 (Pubitemid 43139720)
-
(2006)
Cardiovascular Research
, vol.69
, Issue.3
, pp. 562-573
-
-
Nagase, H.1
Visse, R.2
Murphy, G.3
-
137
-
-
0030609810
-
1.8-Å crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile
-
Betz M, Huxley P, Davies SJ, et al. 1.8-Å crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile. Eur J Biochem 1997;247(1):356-363 (Pubitemid 27319524)
-
(1997)
European Journal of Biochemistry
, vol.247
, Issue.1
, pp. 356-363
-
-
Betz, M.1
Huxley, P.2
Davies, S.J.3
Mushtaq, Y.4
Pieper, M.5
Tschesche, H.6
Bode, W.7
Gomis-Ruth, E.X.8
-
138
-
-
0035819527
-
Development of matrix metalloproteinase inhibitors in cancer therapy
-
Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001;93(3):178-193 • An informative review about MMPIs and cancer therapy. (Pubitemid 32166488)
-
(2001)
Journal of the National Cancer Institute
, vol.93
, Issue.3
, pp. 178-193
-
-
Hidalgo, M.1
Eckhardt, S.G.2
-
139
-
-
34250630512
-
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas
-
DOI 10.1007/s10637-006-9031-6
-
Chu QS, Forouzesh B, Syed S, et al. A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas. Invest New Drugs 2007;25(4):359-367 (Pubitemid 46944843)
-
(2007)
Investigational New Drugs
, vol.25
, Issue.4
, pp. 359-367
-
-
Chu, Q.S.C.1
Forouzesh, B.2
Syed, S.3
Mita, M.4
Schwartz, G.5
Copper, J.6
Curtright, J.7
Rowinsky, E.K.8
-
140
-
-
0032983844
-
Marimastat (BB2516): Current status of development
-
Steward WP. Marimastat (BB2516): current status of development. Cancer Chemother Pharmacol 1999;43(Suppl):S56-60
-
(1999)
Cancer Chemother Pharmacol
, vol.43
, Issue.SUPPL.
-
-
Steward, W.P.1
-
141
-
-
0037348721
-
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of mmp-expressing tumor cells in nude mice
-
DOI 10.1002/ijc.10875
-
Yamamoto A, Yano S, Shiraga M, et al. A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice. Int J Cancer 2003;103(6):822-828 (Pubitemid 36110241)
-
(2003)
International Journal of Cancer
, vol.103
, Issue.6
, pp. 822-828
-
-
Yamamoto, A.1
Yano, S.2
Shiraga, M.3
Ogawa, H.4
Goto, H.5
Miki, T.6
Zhang, H.7
Sone, S.8
-
142
-
-
0032612382
-
New drugs on the horizon: Matrix metalloproteinase inhibitors
-
Rothenberg ML, Nelson AR, Hande KR. New drugs on the horizon: matrix metalloproteinase inhibitors. Stem Cells 1999;17(4):237-240
-
(1999)
Stem Cells
, vol.17
, Issue.4
, pp. 237-240
-
-
Rothenberg, M.L.1
Nelson, A.R.2
Hande, K.R.3
-
143
-
-
0033034041
-
Clinical studies with matrix metalloproteinase inhibitors
-
Brown PD. Clinical studies with matrix metalloproteinase inhibitors. APMIS 1999;107(1):174-180 (Pubitemid 29133538)
-
(1999)
APMIS
, vol.107
, Issue.1
, pp. 174-180
-
-
Brown, P.D.1
-
144
-
-
0033999308
-
Matrix metalloproteinases: Biologic activity and clinical implications
-
Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000;18(5):1135-1149 (Pubitemid 30123793)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.5
, pp. 1135-1149
-
-
Nelson, A.R.1
Fingleton, B.2
Rothenberg, M.L.3
Matrisian, L.M.4
-
145
-
-
0032837028
-
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
-
DOI 10.1111/j.1749-6632.1999.tb07689.x
-
Shalinsky DR, Brekken J, Zou H, et al. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann NY Acad Sci 1999;878:236-270 (Pubitemid 29353575)
-
(1999)
Annals of the New York Academy of Sciences
, vol.878
, pp. 236-270
-
-
Shalinsky, D.R.1
Brekken, J.2
Zou, H.3
McDermott, C.D.4
Forsyth, P.5
Edwards, D.6
-
147
-
-
0035863463
-
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer
-
Rudek MA, Figg WD, Dyer V, et al. Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer. J Clin Oncol 2001;19(2):584-592 (Pubitemid 32112874)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.2
, pp. 584-592
-
-
Rudek, M.A.1
Figg, W.D.2
Dyer, V.3
Dahut, W.4
Turner, M.L.5
Steinberg, S.M.6
Liewehr, D.J.7
Kohler, D.R.8
Pluda, J.M.9
Reed, E.10
-
148
-
-
0027251836
-
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
-
Davies B, Brown PD, East N, et al. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53(9):2087-2091 (Pubitemid 23145731)
-
(1993)
Cancer Research
, vol.53
, Issue.9
, pp. 2087-2091
-
-
Davies, B.1
Brown, P.D.2
East, N.3
Crimmin, M.J.4
Balkwill, F.R.5
-
149
-
-
0031945505
-
Batimastat, a synthetic inhibitor of matrix metahoproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts
-
Giavazzi R, Garofalo A, Ferri C, et al. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. Clin Cancer Res 1998;4(4):985-992 (Pubitemid 28183401)
-
(1998)
Clinical Cancer Research
, vol.4
, Issue.4
, pp. 985-992
-
-
Giavazzi, R.1
Garofalo, A.2
Ferri, C.3
Lucchini, V.4
Bone, E.A.5
Chiari, S.6
Brown, P.D.7
Nicoletti, M.I.8
Taraboletti, G.9
-
150
-
-
0031848158
-
Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites
-
Beattie GJ, Smyth JF. Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin Cancer Res 1998;4(8):1899-1902
-
(1998)
Clin Cancer Res
, vol.4
, Issue.8
, pp. 1899-1902
-
-
Beattie, G.J.1
Smyth, J.F.2
-
151
-
-
0030855863
-
Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat
-
DOI 10.1016/S0959-8049(97)88065-3, PII S0959804997000877
-
Burke F, East N, Upton C, et al. Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat. Eur J Cancer 1997;33(7):1114-1121 (Pubitemid 27310785)
-
(1997)
European Journal of Cancer Part a
, vol.33
, Issue.7
, pp. 1114-1121
-
-
Burke, F.1
East, N.2
Upton, C.3
Patel, K.4
Balkwill, F.R.5
-
152
-
-
0141482154
-
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation
-
Belotti D, Paganoni P, Manenti L, et al. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 2003;63(17):5224-5229 (Pubitemid 37139832)
-
(2003)
Cancer Research
, vol.63
, Issue.17
, pp. 5224-5229
-
-
Belotti, D.1
Paganoni, P.2
Manenti, L.3
Garofalo, A.4
Marchini, S.5
Taraboletti, G.6
Giavazzi, R.7
-
153
-
-
0028129494
-
Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth
-
Koop S, Khokha R, Schmidt EE, et al. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 1994;54(17):4791-4797 (Pubitemid 24276514)
-
(1994)
Cancer Research
, vol.54
, Issue.17
, pp. 4791-4797
-
-
Koop, S.1
Khokha, R.2
Schmidt, E.E.3
MacDonald, I.C.4
Morris, V.L.5
Chambers, A.F.6
Groom, A.C.7
-
154
-
-
0026499369
-
Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo
-
Khokha R, Zimmer MJ, Wilson SM, et al. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 1992;10(6):365-370
-
(1992)
Clin Exp Metastasis
, vol.10
, Issue.6
, pp. 365-370
-
-
Khokha, R.1
Zimmer, M.J.2
Wilson, S.M.3
-
155
-
-
0033044209
-
The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells
-
DOI 10.1023/A:1026438801080
-
Erba E, Ronzoni S, Bassano L, et al. The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells. Ann Oncol 1999;10(5):589-591 (Pubitemid 29305438)
-
(1999)
Annals of Oncology
, vol.10
, Issue.5
, pp. 589-591
-
-
Erba, E.1
Ronzoni, S.2
Bassano, L.3
Giavazzi, R.4
D'Incalci, M.5
-
156
-
-
0032934107
-
Marimastat in recurrent colorectal cancer: Exploratory evaluation of biological activity by measurement of carcinoembryonic antigen
-
DOI 10.1038/sj.bjc.6690079
-
Primrose JN, Bleiberg H, Daniel F, et al. Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen. Br J Cancer 1999;79(3-4):509-514 (Pubitemid 29046227)
-
(1999)
British Journal of Cancer
, vol.79
, Issue.3-4
, pp. 509-514
-
-
Primrose, J.N.1
Bleiberg, H.2
Daniel, F.3
Van Belle, S.4
Mansi, J.L.5
Seymour, M.6
Johnson, P.W.7
Neoptolemos, J.P.8
Baillet, M.9
Barker, K.10
Berrington, A.11
Brown, P.D.12
Millar, A.W.13
Lynch, K.P.14
-
157
-
-
0033509553
-
Marimastat in patients with advanced pancreatic cancer. a dose-finding study
-
Rosemurgy A, Harris J, Langleben A, et al. Marimastat in patients with advanced pancreatic cancer: a dose-finding study. Am J Clin Oncol 1999;22(3):247-252 (Pubitemid 30263316)
-
(1999)
American Journal of Clinical Oncology: Cancer Clinical Trials
, vol.22
, Issue.3
, pp. 247-252
-
-
Rosemurgy, A.1
Harris, J.2
Langleben, A.3
Casper, E.4
Goode, S.5
Rasmussen, H.6
-
158
-
-
14444284598
-
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: Selection of a biologically active and tolerable dose for longer- Term studies
-
Nemunaitis J, Poole C, Primrose J, et al. Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res 1998;4(5):1101-1109 (Pubitemid 28213319)
-
(1998)
Clinical Cancer Research
, vol.4
, Issue.5
, pp. 1101-1109
-
-
Nemunaitis, J.1
Poole, C.2
Primrose, J.3
Rosemurgy, A.4
Malfetano, J.5
Brown, P.6
Berrington, A.7
Cornish, A.8
Lynch, K.9
Rasmussen, H.10
Kerr, D.11
Cox, D.12
Millar, A.13
-
159
-
-
0030055518
-
Tumour marker levels during marimastat therapy [1]
-
DOI 10.1016/S0140-6736(96)24030-9
-
Gore M, A'Hern R, Stankiewicz M, et al. Tumour marker levels during marimastat therapy. Lancet 1996;348(9022):263-264 (Pubitemid 26254203)
-
(1996)
Lancet
, vol.348
, Issue.9022
, pp. 263-264
-
-
Gore, M.1
A'Hern, R.A.2
Stankiewicz, N.3
Slevin, M.4
Millar, W.5
Brown, P.6
Cornish, A.7
Baillet, M.8
-
161
-
-
0034722898
-
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
-
DOI 10.1038/sj.onc.1204097
-
Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000;19(56):6642-6650 (Pubitemid 32197703)
-
(2000)
Oncogene
, vol.19
, Issue.56
, pp. 6642-6650
-
-
Zucker, S.1
Cao, J.2
Chen, W.-T.3
-
162
-
-
37349082926
-
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
-
A well written article about MMPs and their inhibitors
-
Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75(2):346-359 •• A well written article about MMPs and their inhibitors.
-
(2008)
Biochem Pharmacol
, vol.75
, Issue.2
, pp. 346-359
-
-
Raffetto, J.D.1
Khalil, R.A.2
|